Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)PGE1 as Additive Anticoagulant in ECMO-Therapy
Phase 2
Terminated
- Conditions
- Respiratory Distress Syndrome, AdultExtracorporeal Membrane Oxygenation
- Interventions
- First Posted Date
- 2016-09-09
- Last Posted Date
- 2022-02-09
- Lead Sponsor
- Thomas Staudinger
- Target Recruit Count
- 50
- Registration Number
- NCT02895373
- Locations
- 🇦🇹
Medical University of Vienna, Department of Medicine I, Intensive Care Unit, Vienna, Austria
News
No news found